Christophe Mossé appointed as CEO of Arkopharma group
He will oversee Arkopharma’s activities and related activities of Dermapharm Group.
Brings industry expertise from leading groups: Naos, Galderma, Novartis,…
Founded in 1980 in Carros, near Nice, Arkopharma is a pharmaceutical laboratory specialized in phytotherapy, natural medicines, and dietary supplements.
Arkopharma, a European leader in its field, has announced the arrival of Christophe Mossé as CEO (cf. LinkedIn post below)
Christophe Mossé brings a wealth of experience in the pharmaceutical industry, both in France and internationally.
With his expertise, Christophe Mossé will lead Arkopharma’s activities and related operations of Dermapharm Group, and will be the main link between the management teams of the two entities.
Arkopharma is now present in more than 60 countries and is positioned as the European leader in phytotherapy medicines and dietary supplements.
With 1,212 employees and a consolidated turnover of 201 million euros, Arkopharma dedicates 8.5% of its workforce to research and development, with 1,635 registrations and marketing authorizations for medicines.
Health Nice Côte d’Azur
- Artificial intelligence: Team Nice Côte d’Azur mobilized for an AI Business Tour and WAICF 2026
- Nice University Hospital signs an international cooperation agreement with Emirates Hospitals Group (Dubai)
- Caranx Medical, a Nice-based cardiac robotics MedTech startup, set to be acquired for €16.6 million
- AVC continues its expansion with a consolidated base in the Côte d’Azur
- New medical governance at CHU de Nice
- Nice University Hospital (CHU): a living laboratory of hospital transformation
- Caranx Medical announces first clinical use of its AI Software for real-time intra-operative guidance of transcatheter heart valve implantation.
- DimiCare Biotech: a Nice-based innovation among the winners of the i-Lab 2025 competition
- SunWaves-MedTech sets up in Nice to develop the connected medicine of tomorrow
- From Nice, Circum Medtech Pharma continues its industrial expansion
